Joint Filing AgreementJoint Filing Agreement • December 31st, 2019 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2024 • Access Industries Holdings LLC • Services-amusement & recreation services
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this Exhibit is attached is filed on behalf of each of them. Each of them is individually eligible to use the Schedule 13G to which this Exhibit is attached. Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • March 17th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of ordinary shares of MediWound Ltd. Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. In accordance with Rule 13d-1(k)(1), the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D and any amendments thereto with respect to the equity securities (as defined in Rule 13d-1(i)) of the issuer, beneficially
September 21, 2022Company Shareholder Support Agreement • September 26th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
This letter agreement (this “Agreement”) is being delivered to MediWound Ltd., a company organized under the laws of the State of Israel (the “Company”) in connection with that certain Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the investors signatory thereto (the “Purchase Agreement”) by the undersigned shareholders of the Company (each, a “Shareholder” and collectively, the “Shareholders”). Certain capitalized terms used herein are defined in Section 11 hereof. Capitalized terms used but not otherwise defined herein have the respective meanings ascribed to such terms in the Purchase Agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • September 1st, 2023 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended. Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2019 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned agree that this Schedule 13G dated February 14, 2019 relating to the Ordinary Shares, par value NIS 0.01 per share, of MediWound Ltd. shall be filed on behalf of the undersigned.
Joint Filing AgreementJoint Filing Agreement • March 27th, 2020 • Access Industries Holdings LLC • Biological products, (no disgnostic substances)
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • February 21st, 2019 • Access Industries Holdings LLC • Pharmaceutical preparations
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 29th day of June, 2018, by and among BioCanCell Ltd., a company organized under the laws of the State of Israel (the “Company”) and each of the entities and individuals identified in Schedule 1 hereto (the “Investors”).
ContractJoint Filing Agreement • December 21st, 2020 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 9th, 2023 • Access Industries Holdings LLC • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this Exhibit is attached is filed on behalf of each of them. Each of them is individually eligible to use the Schedule 13G to which this Exhibit is attached. Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
ContractJoint Filing Agreement • January 13th, 2020 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2021 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned agree that the attached Schedule 13G dated February 15, 2021 relating to the Common Stock, par value $0.001 per share, of Pandion Therapeutics, Inc. shall be filed on behalf of the undersigned.
ContractJoint Filing Agreement • April 15th, 2021 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • March 12th, 2020 • Access Industries Holdings LLC • Biological products, (no disgnostic substances)
The undersigned agree that the attached Schedule 13G dated March 11, 2020 relating to the Common Stock, par value $0.0001 per share, of Passage Bio, Inc. shall be filed on behalf of the undersigned.
Joint Filing AgreementJoint Filing Agreement • May 3rd, 2021 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
MEDIWOUND LTD. PIGGY-BACK RIGHTS WAIVERPiggy-Back Rights Waiver • September 26th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
Reference is made to the Amended & Restated Registration Rights Agreement (the “A&R Registration Rights Agreement”), dated as of April 6, 2021, by and among MediWound Ltd. (the “Company”) and the shareholders of the Company listed on Schedule A thereto (the “Shareholders”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the A&R Registration Rights Agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2023 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • October 9th, 2019 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned agree that the attached Schedule 13G dated October 9, 2019 relating to the Common Stock, par value $0.0001 per share, of Syndax Therapeutics, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • July 24th, 2020 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned agree that the attached Schedule 13G dated July 24, 2020 relating to the Common Stock, par value $0.001 per share, of Pandion Therapeutics, Inc. shall be filed on behalf of the undersigned.
Joint Filing AgreementJoint Filing Agreement • July 9th, 2018 • Access Industries Holdings LLC • Biological products, (no disgnostic substances)
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • April 2nd, 2020 • Access Industries Holdings LLC • Biological products, (no disgnostic substances)
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • April 25th, 2023 • Access Industries Holdings LLC • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this Exhibit is attached is filed on behalf of each of them. Each of them is individually eligible to use the Schedule 13G to which this Exhibit is attached. Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Joint Filing AgreementJoint Filing Agreement • March 4th, 2022 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 17th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
This AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of this 6 day of April 2021, by and among (i) MediWound Ltd., an Israeli company (the “Company”), and (ii) each holder of the Company’s Ordinary Shares, nominal value NIS 0.01 each (“Ordinary Shares”) listed on Schedule A hereto (the “Shareholders”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 24th, 2020 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned agree that the attached Schedule 13G dated July 24, 2020 relating to the ordinary shares, nominal value £0.05 per share, of Verona Pharma Plc shall be filed on behalf of the undersigned.
ContractJoint Filing Agreement • March 31st, 2020 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • September 26th, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2021 • Access Industries Holdings LLC • Services-amusement & recreation services
The undersigned agree that this Schedule 13G dated February 12, 2021 relating to the Class A common stock, par value $0.001 per share, of Warner Music Group Corp. shall be filed on behalf of the undersigned.
MEDIWOUND LTD. PIGGY-BACK RIGHTS WAIVERPiggy-Back Rights Waiver • February 13th, 2023 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
Reference is made to the Amended & Restated Registration Rights Agreement (the “A&R Registration Rights Agreement”), dated as of April 6, 2021, by and among MediWound Ltd. (the “Company”) and the shareholders of the Company listed on Schedule A thereto (the “Shareholders”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the A&R Registration Rights Agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • July 1st, 2022 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2020 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned agree that the attached Schedule 13G dated February 14, 2020 relating to the Common Stock, par value $0.0001 per share, of Syndax Therapeutics, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2015 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned agree that this Schedule 13G dated February 12, 2015 relating to the Ordinary Shares, par value NIS 0.01 per share, of MediWound Ltd. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 4th, 2021 • Access Industries Holdings LLC • Pharmaceutical preparations
The undersigned agree that the attached Schedule 13G dated February 3, 2021 relating to the Common Stock, par value $0.0001 per share, of Syndax Therapeutics, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2018 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned agree that this Schedule 13G dated February 14, 2018 relating to the Ordinary Shares, par value NIS 0.01 per share, of MediWound Ltd. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Access Industries Holdings LLC • Medicinal chemicals & botanical products
The undersigned agree that this Schedule 13G dated February 14, 2017 relating to the Ordinary Shares, par value NIS 0.01 per share, of MediWound Ltd. shall be filed on behalf of the undersigned.
